21 Feb, EOD - Indian

SENSEX 75311.06 (-0.56)

Nifty 50 22795.9 (-0.51)

Nifty Bank 48981.2 (-0.72)

Nifty IT 40544.5 (-0.79)

Nifty Midcap 100 50486.2 (-1.32)

Nifty Next 50 60466.8 (-0.94)

Nifty Pharma 20385.65 (-1.92)

Nifty Smallcap 100 15636.9 (-0.70)

21 Feb, EOD - Global

NIKKEI 225 38776.94 (0.26)

HANG SENG 23477.92 (3.99)

S&P 6041.75 (-1.74)

LOGIN HERE

companylogoDeccan Health Care Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 542248 | NSE Symbol : | ISIN : INE452W01019 | Industry : Food - Processing - Indian |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
10-Feb-2025 14-Feb-2025 Quarterly Results Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve 1. Unaudited Financial Results (Standalone & Consolidated) along with the Limited Review Report thereon of the Company for the Quarter ended 31st December 2024. 2. Resignation of Mr Ramesh Kumar Non-Executive Independent Director of the Company 3. Allotment of Equity Shares pursuant to conversion of Convertible Warrants to Shri Minto Gupta (Promoter Group) and M/s Krishna Ventures (Person Other than the Promoter) Warrant holders of the Company. 4. Any other business with the permission of the chairman
18-Dec-2024 21-Dec-2024 Conversion Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/12/2024 inter alia to consider and approve 1. To consider and approve the allotment of Equity Shares pursuant to conversion of Convertible Warrants to Krishna Ventures Warrant holder of the Company (Person Other than the Promoter/Promoter Group). 2. To consider and discuss any other business with the permission of the chairman. The Board has approved 1. the conversion of 832000 warrants into equal number equity share and 2. resignation of company secretary and compliance officer (As Per Bse Announcement Dated on 21.12.2024) Revised outcome of the board meeting held on 21st December 2024, due to a typographical error in the year of resiognation. (As Per BSE Announcement Dated on: 23/12/2024)
09-Nov-2024 14-Nov-2024 Accounts Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve 1. Unaudited Financial Results (Standalone & Consolidated) along with theLimited Review Report thereon of the Company for the half year ended 30 September 2024. 2. any other business with the permission of the chairman Outcome of the board meeting for consideration and approval of Unaudited Financial Results for the quarter ended September 2024. (As Per BSE Announcement dated on 14.11.2024)
15-Oct-2024 21-Oct-2024 Conversion Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2024 inter alia to consider and approve 1. the allotment of Equity Shares pursuant to conversion of Convertible Warrants to Dr. Minto Purshotam Gupta Warrant holder and Promoter of the Company. 2. the request of Promoter and Promoter Group of the Company seeking re-classification from the Promoter/Promoter Group Category to Public Category in line of intimation dated 07 Oct 2024. 3. any other business with the permission of the chairman. The Board has approved the conversion of 853334 warrants into equal number equity share and reclassification request of ''promoter and promoter group'' category to ''public'' category. Intimation pursuant to Regulation 31A of SEBI (LODR) Regulations, 2015 and amendments thereof (As Per BSE Announcement Dated on 21.10.2024)
28-Aug-2024 02-Sep-2024 AGM Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2024 inter alia to consider and approve Draft Notice Draft Director Report fixing the date and time of 28th AGM and other business. Board Directors of the Company in its meeting held today i.e. Monday, 02 September 2024 through Video Conferencing have Inter-alia 1. Approved the Notice and Directors Report with Annexures and other documents being part of Annual Report for the Financial Year ended on 31 March 2024. 2. Decided to hold the 28th Annual General Meeting of the Company on Friday, 27 September 2024 at 02.30 PM through video conferencing (VC)/ Other Audio Visual Means (OAVM). 3. and other related business (As per BSE Announcement Dated on 02/09/2024)
25-Jul-2024 31-Jul-2024 Quarterly Results Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2024 inter alia to consider and approve 1. Unaudited Financial Results (Standalone & Consolidated) along with the Limited Review Report thereon of the Company for the Quarter ended June 30 2024. 2. any other business with the permission of the chairman Outcome of Board Meeting held on 31 July 2024 for Approval of Financial Result for the Quarter ended June 2024 and other matters (As per BSE Announcement Dated on 31/07/2024)
09-Jul-2024 12-Jul-2024 Conversion Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/07/2024 inter alia to consider and approve 1. allotment of 604333 Equity Shares pursuant to conversion of Convertible Warrants 2. any other business with the permission of the chairman Deccan Health Care Ltd - 542248 - Board Meeting Outcome for Outcome Of The Board Meeting For Conversion Of Warrants Into Equity Shares Held On 12 July 2024 The Board of Directors of the Company has allotted 6,04,333 Equity Shares of face value of Rs. 10/- each (Premium of Rs. 20/- per equity share) pursuant to exercise of 6,04,333 Convertible Warrants to M/s Focal Ventures Private Limited. Read less.. (As Per BSE Announcement Dated on 12.07.2024)
22-May-2024 29-May-2024 Accounts Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve the Audited Financial Results for the year ended March 31 2024 and Change in Registered Office of the Company within Local Limit. Board of Directors of the Company at this meeting approved the Audited Financial Results and change in the registered office address within the local limits of the city. Financial Results for the Quarter and Year ended 31st March 2024 Change in Registered office within local limits of the City. (As Per BSE Announcement Dated on 29.05.2024)
06-Mar-2024 11-Mar-2024 Change in Directors Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/03/2024 inter alia to consider and approve 1. Appointment(s)/Recruitment(s) of Additional Director(s). 2. Draft Notice of Postal Ballot. 3. Appointment of Scrutinizer and e-voting agency for the postal ballot process. 4. Any other matter incidental and ancillary related to aforesaid above matters. 5. To consider and discuss any other business with the permission of the chairman. With reference to our Intimation vide letter dated Wednesday, March 06, 2024 we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Monday, March 11, 2024 have Inter-alia approved the agenda attached herewith (As per BSE Announcement Dated on 11/03/2024)
29-Jan-2024 06-Feb-2024 Quarterly Results Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve 1. To consider and approve Unaudited Financial Results (Standalone & Consolidated) along with the Limited Review Report thereon of the Company for the Quarter ended December 31 2023. 2. Approval of Appointment(s)/Recruitment(s) of Additional Director(s). 3. Appointment of Internal Auditor for the F.Y. 2023-24. 4. To consider and discuss any other business with the permission of the chairman. As per the pdf attached with the announcement Appointment of Additional Directors (Independent and Non-Independent Category) (As Per BSE Announcement Dated on: 06/02/2024)
18-Dec-2023 21-Dec-2023 Others Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/12/2023 inter alia to consider and approve 1. To Discuss Deliberate and Approve Potential Opportunities associated in Foreign Market and Incorporating Subsidiaries accordingly if required and deemed necessary. 2. Appointment(s)/Recruitment(s) of Additional Director(s). 3. To consider and discuss any other business with the permission of the chairman. Kindly take the above information on your records. With reference to our Intimation vide letter dated Monday, December 18, 2023 we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Thursady, December 21, 2023 through Video Conferencing/OAVM have Inter-alia; 1. Discussed the opportunities associated in the foreign market and decided to incorporate subsidiaries of Deccan Health Care Limited, initially in USA and UAE for the presence in the International market subject to the approval of shareholders. Further details of General Meeting will be shared at the earliest. 2. Discussed the profile of the candidate on the recommendation of Nomination and Remunaration Committee and agreed to complete the requirements on the documentation part. The board will take up this agenda in next board meeting for the confirmation after completing the procedural requirement as needed. Further the details of candidate with profile will be shared after the approval of Board in upcoming Board Meeting. (As Per BSE Announcement Dated on 21/12/2023)
03-Nov-2023 11-Nov-2023 Quarterly Results Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2023 inter alia to consider and approve 1. To consider and approve Unaudited Financial Results (Standalone & Consolidated) along with the Limited Review Report thereon of the Company for the Quarter ended September 30 2023. 2. Any other business with the permission of the Chair. In this connection and in continuation of our intimation regarding Closure of Trading Window for the Insiders of the Company the trading window for dealing in the securities of the Company is already closed for the Insiders of the Company since October 01 2023 and the same shall open 48 hours after declaration of Financial Results of the company. With reference to our Intimation vide letter dated Friday, November 03, 2023 we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Saturday, November 11, 2023 through Video Conferencing/OAVM have Inter-alia; 1. Considered and Approved the Standalone Unaudited Financial Results of the Company for the quarter ended September 30, 2023 along with the Limited Review Report. 2. Considered and Approved the Consolidated Unaudited Financial Results of the Company for the quarter ended on September 30, 2023 along with the Limited Review Report. The Board Meeting commenced at 11:30 AM and concluded at 11:50 AM (As Per BSE Announcement Dated on 11.11.2023)
09-Oct-2023 12-Oct-2023 Preferential Issue Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/10/2023 inter alia to consider and approve 1. To allot Equity Shares and/or Convertible Warrants on the basis of preferential allotment to Promoter/Persons belong to promoter Group and Person other than Promoters/Promoters Group of the Company. 2. Any other matter incidental and ancillary related to aforesaid above matters. 3. To consider and discuss any other Business with the permission of the Chairman. 1. Pursuant to the approval of the Members and receipt of Cash consideration in full, the Company has approved the allotment of 33,33,000 Equity Shares of Rs. 10 each of the Company, at a price of Rs. 30/- per share to person other than promoter and Promoter Group 2. Pursuant to the approval of the Members and Pursuant to the receipt of the 25% of Issue Price / subscription money, the Company has considered and approved the allotment of 53,73,000 Convertible Warrants at a price of Rs. 30/- per Warrants to Promoter and Person other than Promoter and Promoter Group The Board Meeting commenced at 03:30 PM and concluded at 03:45 PM. (As per BSE Announcement Dated on 12/10/2023)
01-Sep-2023 01-Sep-2023 AGM The Board Directors of the Company in its meeting held today i.e. Friday, September 01, 2023 through Video Conferencing/OAVM have Inter-alia considered and approved the business as attached herewith.
22-Aug-2023 28-Aug-2023 Raising funds through Debt Instr. Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/08/2023 ,inter alia, to consider and approve 1. Raising of funds by way of Issue of Equity Shares /convertible warrants to Promoters / Promoters Group and person(s) other than promoters / Promoter Group on preferential basis, subject to obtaining approval of the shareholders of the Company. 2. Increase in authorized capital (if required) 3. Any other matter incidental and ancillary related to aforesaid above matters. 4. To consider and discuss any other Business with the permission of the Chairman. Further, the Trading Window will be closed with immediate effect and will continue to remain close till 48 hours after the submission of outcome of the Board Meeting to be held on Monday, August 28, 2023. Accordingly, all the designated persons /insiders of the Company are hereby informed that not to trade in the equity shares of the Company during the aforesaid period of closure of trading window we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Monday, August 28, 2023 through Video Conferencing/OAVM have Inter-alia considered and approved the following; 1. Issuance of Equity Shares and Warrants by way of Preferential Allotment 2. Increase in Authorised Share Capital of the Company and consequent alteration of Memorandum of Association 3. Convening Shareholders Approval through Postal Ballot. 4. The Board appointed Ms. Monika Bhatia (M/s M R Bhatia & Co), Company Secretary in practice as a scrutinizer to scrutinize the votes cast by the members through remote e-voting for Postal Ballot process in a fair and transparent manner. The Board Meeting commenced at 04:30 PM and concluded at 05:00 PM. (As per BSE Announcement Dated on 28/08/2023)
1 2 3 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +